Skip to main content
. 2021 Nov 9;36(1):e14515. doi: 10.1111/ctr.14515

TABLE 2.

Separate outcomes of the composite cardiovascular endpoint

Cardiovascular events Overall (N = 174) N (%) TASC II stenosis (N = 55) N (%) Control (N = 119) N (%) P‐value

Ischemic heart disease

92 (52.6)

26 (46.4)

66 (55.5)

.311
Non‐hemorrhagic cerebrovascular disease 25 (14.3) 7 (12.5) 18 (15.1)
Peripheral arterial disease 58 (33.1) 23 (41.1) 35 (29.4)